MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-02-0059295
Escientia Biopharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹20.04 Cr
▼ 79% YoY
Net loss · FY 2025
₹12.35 Cr
Net margin -61.6%
EBITDA · FY 2025
-₹9.28 Cr
EBITDA margin -46.3%
Authorised capital
₹1.5 Cr
Registered with MCA
Paid-up capital
₹1.12 Cr
Issued & subscribed
Company age
18 yrs
Est. 2008
Employees · EPFO
163
Provident fund records
Directors on board
7
As per MCA filings
About Escientia Biopharma Private Limited
Data last updated:
Escientia Biopharma Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Deccan Advanced Sciences Private Limited. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 22 January 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2008PTC057277. Its GSTIN is 36AABCE8967G1ZA (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹1.12 Cr. It is led by directors including Pendri Kiran Reddy and Dandu Chakradhar.
Its last annual general meeting (AGM) was held on 17 November 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1 – 9 – 815 Adickmet Near Railway Crossing, Hyderabad, Telangana, India – 500044.
As per the financials filed for FY 2025, the company reported a revenue of ₹20.04 Cr, a decline of 79% compared to the previous year. For the same year it recorded a net loss of ₹12.35 Cr (net margin -61.6%) and EBITDA of -₹9.28 Cr (EBITDA margin -46.3%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 19% over five years.
The company has about 163 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Escientia Lifesciences. Court records list 35 cases involving the company, including 1 filed by the company and 34 filed against it; 19 cases are pending. The company has 4 deals on record (2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹1.11 Cr; the latest was in August 2020. The company has 4 MSME Form 1 returns on record between 2020 and 2024, listing 42 overdue payments to 8 micro and small suppliers.
Escientia Biopharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0059295). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website escientia.com.
Company details
CIN U24100TG2008PTC057277
Registration Number 057277
Incorporation Date 22 January 2008
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 17 November 2025
Date of Balance Sheet 31 March 2025
Parent Company Deccan Advanced Sciences Private Limited
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-02-0059295
CIN history
Escientia Biopharma has one previous CIN (Corporate Identification Number): U24100AP2008PTC057277. The current CIN is U24100TG2008PTC057277, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100TG2008PTC057277 | Current |
| U24100AP2008PTC057277 | Previous |
Recognitions & Rankings of Escientia Biopharma
Contact details
Escientia Biopharma Private Limited's registered office is in Hyderabad, Telangana. Its website is escientia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address1 – 9 – 815 Adickmet Near Railway Crossing, Hyderabad, Telangana, India – 500044
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Escientia Biopharma Private Limited, buy the company report.
Comprehensive company report
Escientia Biopharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Escientia Biopharma operates one associated brand: Escientia Lifesciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Technology-oriented manufacturing services for pharmaceutical and biotechnology firms are provided. | escientia.com |
Business activity
The main business activities of Escientia Biopharma are manufacturing and professional, scientific and technical. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and scientific research and development. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Escientia Biopharma Private Limited, buy the company report.
Financials of Escientia Biopharma Private Limited
FY 2025 filings availableEscientia Biopharma Private Limited reported revenue of ₹20.04 Cr (down 79% YoY) for FY 2025.
Revenue · FY 2025
₹20.04 Cr ▼ 79%
Net loss · FY 2025
₹12.35 Cr margin -61.6%
EBITDA · FY 2025
-₹9.28 Cr margin -46.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 79%
3 years · compounded
▼ 14%
5 years · compounded
▲ 19%
EBITDA CAGR growth
1 year
▼ 122%
3 years · compounded
▼ 42%
5 years · compounded
▼ 89%
Revenue fell 79% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 19%. EBITDA fell 122% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹9.28 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹12.35 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -46.3% | ||||
| Net Profit Margin | -61.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Escientia Biopharma Private Limited, buy the company report.
Board of directors of Escientia Biopharma Private Limited
Escientia Biopharma has 7 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pendri Kiran Reddy Also directs: Escientia Advanced Sciences Private Limited | Director | 10 Nov 2008 | 17 Years 11 Months | Current |
| Dandu Chakradhar | Director | 19 Aug 2020 | 6 Years 2 Months | Current |
| Ajit Alexander George Also directs: Escientia Advanced Sciences Private Limited | Director | 24 Jun 2023 | 3 Years 4 Months | Current |
| Varadarajan Purushothaman | Director | 18 Jul 2023 | 3 Years 3 Months | Current |
| Yadagiri R Pendri | Director | 22 Jan 2008 | 18 Years 9 Months | Current |
| Suresh Chandra Partani Also directs: Partani Appliances Limited | Director | 22 Jan 2008 | 18 Years 9 Months | Current |
Showing 6 of 7 current directors. View all directors
Auditor
Escientia Biopharma Private Limited is audited by MSKA and Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MSKA and Associates | FY 2023 | 105047W |
Shareholding
The shareholding of Escientia Biopharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Escientia Biopharma Private Limited, buy the company report.
Deals & funding
Escientia Biopharma Private Limited has 4 deals on record (2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹1.11 Cr; the latest was in August 2020.
Total deals
4
Funding rounds
2
Secondary share transfers
2
Disclosed funding
₹1.11 Cr
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2020 | Secondary share transfer | Undisclosed | Buyer: Deccan Advanced Sciences Private Limited , an individual Seller: 2 individuals |
| Oct 2018 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Feb 2010 | Funding round | ₹97.6 Lakh | Investors: an individual |
| Jun 2008 | Funding round | ₹13 Lakh | Investors: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Escientia Biopharma Private Limited has 35 court cases on record: 1 filed by Escientia Biopharma, 34 filed against it. 19 cases are pending and 16 are disposed.
Total cases
35
Filed by the company
1
Filed against the company
34
Pending
19
Disposed
16
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| NCLAT | 32 | 32 | 18 |
| NCLT | 2 | 1 | 1 |
| Supreme Court | 1 | 1 | 0 |
Cases on record (5 of 35)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLAT, NCLAT Chennai | Company appeal | Filed against the company by Deccan Advanced Sciences Pvt Ltd | Pending |
| NCLAT, NCLAT Chennai | Interim or miscellaneous application | Filed against the company by Deccan Advanced Sciences Pvt Ltd | Pending |
| NCLT, NCLT Hyderabad | Court case (Ivn.P) | Filed by the company against Escientia Advanced Sciences Pvt Ltd | Pending |
| NCLAT, NCLAT Chennai | Interim or miscellaneous application | Filed against the company by Deccan Advanced Sciences Pvt Ltd | Disposed |
| NCLAT, NCLAT Chennai | Company appeal | Filed against the company by individuals | Pending |
To see the full case history of Escientia Biopharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Escientia Biopharma Private Limited has 4 MSME Form 1 returns on record between 2020 and 2024, listing 42 overdue payments to 8 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 8)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Obvez Labs Private Limited | |||
| an individual supplier | |||
| Hyderabad Tubes & Ducts Private Limited | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Escientia Biopharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Escientia Biopharma Private Limited has a workforce of 163 employees on its EPFO records as of Mar 30, 2024, across 1 active EPFO establishment.
Employee count
163
Active EPFO establishments
1
Employee growth
13.19%
GST
Escientia Biopharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AABCE8967G1ZA | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Escientia Biopharma Private Limited, buy the company report.
Recent activity
Escientia Biopharma Private Limited has 13 board changes on record since 2008: 7 appointments and 6 cessations. The latest: Varadarajan Purushothaman ceased to be Additional Director on 11 Aug 2023.
AGM
Escientia Biopharma Private Limited last Annual general meeting of members was held on 17 Nov 2025 as per latest MCA records.
Filing
Escientia Biopharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Varadarajan Purushothaman ceased to be Additional Director.
Appointed
Varadarajan Purushothaman was appointed as Director.
Appointed
Ajit Alexander George was appointed as Director.
Ceased
Dandu Chakradhar ceased to be Additional Director.
Ceased
Dwarakanath Srinivas Rachmadagu ceased to be Additional Director.
Ceased
Vivek Vasant Save ceased to be Additional Director.
Appointed
Dandu Chakradhar was appointed as Director.
Appointed
Vivek Vasant Save was appointed as Director.
Ceased
Anjaneyulu Reddy Pendri ceased to be Director.
Ceased
Pendri Kiran Reddy ceased to be Additional Director.
4 earlier events are in the company report.
Frequently asked questions
Escientia Biopharma is an active private limited company based in Hyderabad, Telangana, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 22 January 2008 (18+ years old) and is registered under CIN U24100TG2008PTC057277.
Escientia Biopharma has 7 current directors:
- Pendri Kiran Reddy - Director
- Dandu Chakradhar - Director
- Ajit Alexander George - Director
- Varadarajan Purushothaman - Director
- Yadagiri R Pendri - Director
- Suresh Chandra Partani - Director
- Vivek Vasant Save - Director
The latest financial statements of Escientia Biopharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 17 November 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Escientia Biopharma is 36AABCE8967G1ZA, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Escientia Biopharma is U24100TG2008PTC057277. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Escientia Biopharma has 35 court cases on record: 1 filed by the company and 34 filed against it. 19 are pending. Most are in the nclat.
Escientia Biopharma was incorporated on 22 January 2008, making it 18+ years old. It is registered with the Registrar of Companies, Hyderabad.
Escientia Biopharma has 4 deals on record (2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹1.11 Cr; the latest was in August 2020.
Varadarajan Purushothaman ceased to be Additional Director on 11 Aug 2023. Varadarajan Purushothaman was appointed as Director on 18 Jul 2023. Ajit Alexander George was appointed as Director on 24 Jun 2023. Escientia Biopharma has 13 board changes on record in total.
Yes, Escientia Biopharma is registered as a small enterprise under Udyam registration (number: UDYAM-TS-02-0059295).
Escientia Biopharma has 4 MSME Form 1 returns on record between 2020 and 2024, listing 42 overdue payments to 8 micro and small suppliers. The latest return was filed on 30 Apr 2024.